Sales Endring Dato
AbbVie USD 14.3B 374M 2023-12
Acorda Therapeutics USD 27.72M 1.96M 2023-09
Amgen USD 8.2B 1.29B 2023-12
Anika Therapeutics USD 42.97M 1.51M 2023-12
Arrowhead Research USD 3.55M 12.55M 2023-12
AstraZeneca USD 12.02B 532M 2023-12
BioCryst Pharmaceuticals USD 93.4M 6.66M 2023-12
Biogen USD 2.39B 144M 2023-12
Bristol-Myers Squibb USD 11.48B 511M 2023-12
Enanta Pharmaceuticals USD 18M 929K 2023-12
Gilead Sciences USD 7.12B 64M 2023-12
GlaxoSmithKline GBP 8.05B 95M 2023-12
Halozyme Therapeutics USD 230.04M 14.01M 2023-12
Heron Therapeutics USD 34.23M 2.8M 2023-12
Incyte USD 1.01B 94.32M 2023-12
Insmed USD 83.69M 4.62M 2023-12
Ionis Pharmaceuticals USD 325M 180.79M 2023-12
J&J USD 21.4B 44M 2023-12
Karyopharm Therapeutics USD 33.75M 2.26M 2023-12
Ligand Pharmaceuticals USD 28.1M 4.77M 2023-12
Marinus Pharmaceuticals USD 7.19M 148K 2023-12
Merck USD 14.63B 1.33B 2023-12
Neurocrine Biosciences USD 515.2M 16.4M 2023-12
Novartis USD 11.78B 316M 2023-12
Novavax USD 291.34M 104.36M 2023-12
Pfizer USD 14.25B 1.02B 2023-12
PTC Therapeutics USD 307.06M 110.48M 2023-12
Roche Holding CHF 28.94B 842M 2023-12
Sarepta Therapeutics USD 396.78M 64.96M 2023-12
Vertex Pharmaceuticals USD 2.52B 34.2M 2023-12



Enanta Pharmaceuticals Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2024.